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Since Fleming discovered penicillin, pharmaceutical companies began producing antibiotics on a large-scale in 
the so-called “antibiotic gold-era”, making it easier to ight bacterial infections1,2. Unfortunately, the misuse of 
these antimicrobial compounds created a selective pressure in favor of antibiotic resistant bacteria leading to 
an overall increase of antimicrobial resistance (AMR)3,4. he World Health Organization (WHO) have cam-
paigned against the threat of AMR with initiatives such as the Global Antimicrobial Resistance Surveillance 
System (GLASS); Global Antibiotic Research and Development Partnership (GARDP), and the Interagency 
Coordination Group on Antimicrobial Resistance (IACG). hus, the search for new/alternative antimicrobial 
agents is a global grand challenge5.
Transition metals and their compounds, for example, silver and silver salts, are among the most studied alter-
natives to ight sensitive and resistant bacteria6,7. Metal nanoparticles, especially silver nanoparticles, have been 
used for a variety of biomedical applications8 like antimicrobial, antibioilm activity, larvicidal and insecticidal 
efects, and anticancer activity9–12. Nevertheless, the use of such metals in therapeutic agents is limited by their 
toxicity on eukaryotic cells. To overcome their cytotoxic behavior, combinatorial formulations of transition met-
als have been proposed13–15, such as the use of microbial extracts or biopolymers as capping agents of metal 
nanoparticles (NPs) to obtain biocomposites16–19. Biocomposites, as well as metal nanoparticles, are commonly 
synthesized using green methodologies20–26. hese methodologies are eco-friendly, eliminate the use of toxic 
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chemicals, and allow the use of biocomposites in a variety of biological applications27. he typical capping agents 
employed on the synthesis of biocomposites are long-chain hydrocarbons, polymers, or co-polymers.
Herein, the inherent hydroxyl functionality of cellulose is considered in the preparation of a novel silver nan-
oparticle biocomposite. here is no shortage of cellulose as it is the most abundant biopolymer on the planet, and 
is also readily available from waste residues such as the unavoidable food supply chain waste. One of the more 
recent advances in food waste processing is the use of microwave technology as an alternative to conventional 
heating means. he use of microwaves to valorize citrus residues has received much attention in the past decade 
and has successfully been shown to produce materials such as limonene, pectin, and cellulose28.
Cellulose is a long-chain homopolymer comprising repeating β-(1-4)-glycosidic bonds. Its abundance, renew-
ability, low toxicity, biocompatibility, and ease of biodegradation makes it a promising and exciting biomate-
rial for use in biomedical applications, namely, biocomposites to combat AMR. Diferent types of cellulose with 
distinct morphological and mechanical diferences are available for composites formulation, such as vegetable 
cellulose (VC), bacterial cellulose (BC), and nanoibrillated cellulose (NFC)29. From these, BC has increased 
in popularity due to its high purity, crystallinity, and mechanical stabilization. However, BC production is very 
complicated and expensive due to high culture media costs and low rates of production30,31. herefore, greener 
processes for industrial-scale production of cellulose ibers are under receiving increasing attention. Promising 
results are being obtained in the biomedical ield for optimum wound dressings by enhancing in vivo skin repair 
in less than 14 days as reported by Singla et al. 2017 where cellulose nanocrystals from bamboo, as an alternative 
for BC, were obtained and functionalized with green AgNPs32. hus, the use of cellulose in the synthesis of NP 
biocomposites could increase scalability, decrease production costs, reduce reaction time and increase safety33,34
Meanwhile, Life Cycle studies estimate that the increased energy eiciency from microwave technology has 
the potential to reduce many environmental impacts (e.g., climate change, ozone depletion, eutrophication, etc.) 
by ~75%35. he use of microwaves to produce cellulose from citrus peel can tune the properties of the resulting 
ibers according to processing temperature36. However, whilst the diferent chemical and physical properties of 
the cellulose have been established, there have been no studies on how these function in antimicrobial applica-
tions as of yet. Herein, AgNPs biocomposite synthesized using ascorbic acid as a reducing agent and microi-
brillated cellulose, derived from orange peel waste, as a capping agent for the irst time is here reported. Also, 
its antimicrobial activity against sensitive and resistant bacteria is also explored using an inverse disk difusion 
method proposed here to the use of low water solubility compounds, like cellulose compounds.

Materials. Microibrillated cellulose (hereater called cellulose) from orange peel waste was obtained via acid-
free microwave hydrothermal treatment at 120 °C, as reported by de Melo et al.36. Ascorbic acid and AgNO3 
were purchased from Jalmek, Mexico. HCl (12 M) and NaOH were purchased from Desarrollo de especialidades 
químicas S.A de C.V., Mexico. Müller-Hinton broth was purchased from DIFCO, USA. Agar was purchased from 
BD Bioxon, Mexico.
Bacterial strains. he bacteria strains used in this work were Escherichia coli ATCC 11229, Staphylococcus 
aureus ATCC 6538, Pseudomonas aeruginosa ATCC 27853, and two clinical isolates proportioned kindly by 
Hospital San José (Monterrey, Nuevo León, México) multidrug resistant Staphylococcus aureus and Pseudomonas 
aeruginosa.
ǦǤ A mixture of orange peel cellulose (5000 ppm) and ascorbic 
acid (4%w/v) contained in a 50 mL tube was adjusted to pH 10 with NaOH and HCl and heated to 60 °C under 
constant agitation (600 rpm). To this, the necessary volume of AgNO3 (100 mM) was added until the 40 mL mark 
was achieved thus giving a mixture comprising cellulose (1000 ppm), ascorbic acid (1%) and AgNO3 (10 mM). 
The resultant nanoparticle composite was isolated by centrifugation (12 000 rpm for 15 min), washed (3 x 
ultrapure water at 12 000 rpm for 15 min), dried (SPD2010 SpeedVac, hermoFisher Scientiic, USA) for a total of 
5 h, heating 1 h at 45 °C, and stored for further experiments.
ǦǤ he synthesis of silver nanoparticles in the cellulose 
was observed by UV-Vis spectrophotometry (from 300–600 nm), scanning electron microscopy (SEM), and 
transmission electron microscopy (TEM)36. For SEM, samples were dried and covered with gold/palladium 
(around 4 nm thickness) then analyzed on a JEOL JSM-7600F SEM. TEM images of cellulose were acquired using 
a TEM Tecnai 12 BioTWIN (manufactured by FEI) coupled to a SIS Megaview 3 camera at acceleration voltage 
of 120 kV. Before the analysis, diluted samples (0.2% aqueous) were sonicated for 30 min using an ice-cold ultra-
sound bath (output of 1200 W). Drops of the sample (about 8 µL) were let on the grid for 5 min, then negatively 
stained with 1% uranyl acetate and inally glow discharged. Copper grids with a formvar/carbon support ilm 
were used.
ơǦǤ Antimicrobial activity was assessed culturing 
the appropriate bacteria (E. coli, P. aeruginosa, resistant P. aeruginosa, S. aureus, and resistant S. aureus) in agar 
mixed with the synthesized composite. A certain amount of composite was taken to achieve concentrations of 
2000, 1500, 1000, 500, 250, 125, 62, and 31 ppm in 50 mL of Müller-Hinton agar (Müller-Hinton broth with 2% 
of agar), sonicated until complete dispersion and emptied into sterile Petri dishes. From an overnight culture 
(16 h, 150 rpm at 37 °C) of each strain, 200 µL were transferred to a tube with fresh media and incubated at 37 °C 
(150 rpm) until an optical density at 600 nm (OD600) of 0.2 ± 0.02 was reached. hen, a 1:200 dilution was made to 
achieve a cellular concentration of ~1×105 CFU/mL, and 10 µL of culture was plated in every concentration Petri 
dish and incubated at 37 °C for 20 h. Ater the incubation, the growth of bacteria was observed in every concen-
tration plate. All experiments were conducted in triplicate.
3SCIENTIFIC REPORTS |         (2020) 10:7281  | ǣȀȀǤȀ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?Ǧ ? ? ?Ǧ ? ? ? ? ?Ǧ ?
www.nature.com/scientificreportswww.nature.com/scientificreports/

ǦǤ he synthesis of metal nanoparticles 
was carried out through a green methodology were either none or reduced environmentally toxic agents were 
employed. he synthesis used an eco-friendly reducing agent, ascorbic acid, commonly used in the synthesis of 
metal nanoparticles25,37,38. he successful formation of silver nanoparticles (AgNPs) was observed using UV-Vis 
spectrophotometry (Fig. 1a). his was evidenced by the formation of the characteristic surface plasmon reso-
nance (SPR) absorbance band centered at 407 nm, commonly reported around 420 nm39–41, the lack of a band in 
the cellulose spectrum and visually, via color change (light yellow to black to grey), indicative of the redox reac-
tion between the Ag salt and ascorbic acid (Fig. 1b). his color was persistent in the AgNPs-cellulose compound 
during three months of realization of the remaining experiments, suggesting that the cellulose used in this work 
provides good stability to the synthesized AgNPs42.
he formation of AgNPs within a deibrillated cellulosic matrix was further evidenced by SEM (Fig. 2a,b) and 
TEM (Fig. 2c,d). hese images show that the AgNPs obtained are spherical and caped with the cellulose matrix. 
Several works reported the obtention of spherical AgNPs when ascorbic acid was used as a reducing agent, where 
the size of the AgNPs varies depending on the capping agent, pH value, and reaction time used in the synthe-
sis43–45. Here, the capping efect induced by the cellulosic substrate gave an average size of 140.79 ± 85.41 nm 
AgNPs. hese physical characteristics of the material are due to the speciic synthesis conditions established and 
reported in this work reaction regarding time and pH values46. As reported36, the cellulose used in this work has 
a high amount of hydroxyl groups as well as substantial intra- and intermolecular hydrogen bonding interac-
tions, characteristic of cellulose compounds47. hese chemical groups could be involved in the stabilization of the 
AgNPs by anchoring silver ions into the cellulose ibers and stabilizing the AgNPs due to the interaction between 
cellulose hydrogen bonds and the metal nanoparticle25,48. Also, the use of microwave technology to produce the 
cellulose also presents the opportunity to reduce the environmental impact of its production signiicantly com-
pared to other materials in the ield36.
ơǦǤ he antimicrobial activity against a selected 
group of the clinically relevant ESKAPE pathogens49–52 (Staphylococcus and Pseudomonas resistant strains) is here 
reported for a synthesized metal biocomposite. To assess the antimicrobial activity of certain compounds, the 
Minimum Inhibitory Concentrations (MIC) obtained from the disk difusion method is a well-accepted param-
eter, but this method depends directly on the facile difusion of the antimicrobial agent in the agar. Cellulose 
compounds, like the AgNP composite synthesized here, are known to have low solubility in water, and therefore 
in agar as well, in contrast to AgNPs capped with water-soluble compounds, which exhibit favorable antimicrobial 
activity by this methodology53,54. Besides, the difusion of silver, in silver-containing materials, could be limited 
by the composition of the media used for the determination of inhibition zones55. hus, an inverse disk difusion 
method was used, which involves dispersing the biocomposite in the agar and placing the bacteria as “disks” at a 
known concentration.
he MICs obtained are reported in Table 1. Both Gram positive strains (S. aureus and resistant S. aureus) 
were inhibited at 1500 ppm, whereas the Gram negative strains (E. coli, P. aeruginosa and resistant P. aeruginosa) 
needed only 125 ppm for complete inhibition. hese behaviors have been reported for bare and coated AgNPs and 
could be due to the diferences in the cell membrane as Gram positive bacteria have a thicker peptidoglycan layer 
that could prevent the penetration of our biocomposite into the cell cytoplasm56–58. Moreover, recent reports of 
AgNPs-cellulose biocomposites against E. coli have shown good inhibition zones values of 15–22.5 mm reliant on 
Figure 1. UV-Vis spectrum of silver nanoparticles synthesized in the cellulose matrix. (a) silver nanoparticle 
peak of 407 nm; (b) color change of the AgNPs synthesis.
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the aq. AgNO3 solution concentration which varied from 4 mM to 250 mM (from 430 to 26 000 ppm of Ag)
59–61. 
Similarly, reports of AgNPs-cellulose compounds against S. aureus have shown good inhibition zones, using aq. 
Ag concentrations from 1 mM to 79 mM (from 107 to 8521 ppm)62–64. Taking a total reduction of the AgNO3 
used, the Ag:cellulose ratio in 1 mg of the synthesized compound is calculated to be 0.519:0.418 mg. hus, the 
MICs of 125 ppm, obtained for the Gram negative strains, and 1500 ppm, obtained for the Gram positive strains, 
would have a total of 64 and 778 ppm of silver, respectively. hereby, our Ag-cellulose composite shows an ei-
ciency ive times higher set of against the most optimum clear zone value obtained for Gram negative strains and 
up to 10 times higher for Gran positive strain according to the literature. his composite represents an attractive 
alternative to the treatment of infectious diseases caused by bacteria, especially the bacteria strains used in this 
work, as they are included in the ESKAPE groups, which, as mentioned above, represent an important clinical 
threat49. Figure 3 shows the bacterial growth of the untreated control, a sub-inhibitory concentration, and the 
MIC. As AgNPs concentration increases, agar medium color intensiies to a darker grey. hence the lowest tonal-
ity is present at 62 ppm and the darkest plate at 1500 ppm.
Figure 2. Electron microscopy images of AgNPs in cellulose. (a) and (b) SEM, (c,d) TEM images of the AgNPs 
synthesized in the cellulose matrix, white arrows point AgNPs, and black arrows point deibrillated cellulose.
Microorganism MIC (ppm)
Escherichia coli ATCC 11229 125
Pseudomonas aeruginosa ATCC27853 125
Resistant Pseudomonas aeruginosa 125
Staphylococcus aureus ATCC 6538 1500
Resistant Staphylococcus aureus 1500
Table 1. Minimum inhibitory concentration of the synthesized AgNP composite.
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A novel biocomposite containing AgNPs was synthesized using deibrillated cellulose. he methodology pro-
posed in this work to determine the antimicrobial activity was relevant as the biocomposite was homogeneously 
dispersed in the agar plate, overcoming the low difusion it would have if placed in conventional disks. Also, 
the novel biocomposite showed antimicrobial activity against reference bacteria strains as well as against rele-
vant clinical multidrug-resistant strains and showed a stronger antimicrobial activity against Gram negative than 
Gram positive bacteria. Based on the results reported in this manuscript, this biocomposite can be considered for 
further studies regarding its application in biomedical ields.
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